endovascular.es

Título: Biotronik's Passeo-18 Lux drug releasing balloon shows positive six-month study results
Fecha: 06-03-2014
Biotronik announced on Thursday positive six-month data from the BIOLUX P-II study of the performance of the Passeo-18 Lux Drug Releasing Balloon (DRB) in the treatment of vascular occlusions of the lower extremities compared to uncoated percutaneous transluminal angioplasty (PTA) catheters. 'The results of BIOLUX P-I and P-II confirm Passeo-18 Lux DRB as a safe and effective therapy option for both above- and below-knee arterial disease,' said Alexander Uhl, vice president of marketing.
Fuente: endovascular.es

endovasculares.es